DMK Pharmaceuticals Corp
DMKDelisted Mar 21, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000887247
DMK Pharmaceuticals Corp was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 29 institutions reported holding it in 13F filings for Q4 2023, worth $350.4K in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding DMK Pharmaceuticals Corp changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 22 | 1 | 25 | +4 |
| Shares | 114.9K | 72 | 259.2K | +144.4K (+125.8%) |
| Value | $276.4K | $174 | $178.7K | −$97.5K (−35.3%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held DMK Pharmaceuticals Corp at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 29,708 | $20.5K | 0.00% |
| Virtu Financial LLC | 18,719 | $13.0K | 0.00% |
| StoneX Group Inc. | 13,258 | $9.13K | 0.00% |
| XTX Topco Ltd | 12,024 | $8.29K | 0.00% |
| Qube Research & Technologies Ltd | 100 | $69 | 0.00% |
| Cornerstone Planning Group LLC | 7 | $5 | 0.00% |
Sold out (2)
Institutions that held DMK Pharmaceuticals Corp at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Cubist Systematic Strategies, LLC | 13,655 | $32.9K |
| Founders Capital Management | 71 | $171 |
Not filed for Q3 2023 yet (1)
Institutions that held DMK Pharmaceuticals Corp at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Coastal Capital Group, Inc. | 72 | $174 |